Mike Moradi

Kauffman Fellow (KF29)

2024 - Current

Co-Founder & General Partner

2020

Co-Founder & CEO

2014

Sensulin is developing a glucose-responsive insulin for treatment of type I/II diabetes, which aims to make basal and prandial (mealtime) insulin obsolete, and eliminate the need for regular monitoring, thus giving insulin-dependent patients a chance at a normal life.

Young Global Leader

2017

Member, Board of Directors, Investment Committee

2022

Grand Founders is a New York-based foundation that supports economic development globally through its impact investments into emerging entrepreneurs, ensuring a noble legacy for generations to come. As a Board Member, I’ve committed to helping Grand Founders establish financial, social, and professional legacies across emerging economies while upholding the strictest adherence to good governance principles.

Founder & CEO

2005 - 2009

Charlesson is an Oklahoma-based pharmaceutical company, which operates EyeCRO, a specialty ocular CRO. The company develops therapeutics for eye diseases, including pharmaceutical treatments for Age-Related Macular Degeneration, Diabetic Retinopathy, Ocular Inflammation, and Glaucoma.

General Partner

2005 - 2007

Atomic Venture Partners is an early stage venture capital fund with offices in the Silicon Valley, Boston, and OKC. AVP invests in early stage companies that leverage cutting-edge technology for “game-changing” results - which address very large potential markets and have compelling high margin business models. We add significant value beyond the capital that we invest: AVP is led by successful venture-backed entrepreneurs and technology executives, who have founded several best-of-breed companies in our target industries. This provides to entrepreneurs an intimate understanding of our chosen industries, the ability to provide a vast network, and an invaluable operational skill set for explosive growth. The Fund invests in the following areas: Semiconductors; Pharmaceuticals; Digital Media; and Nanotechnology.

Co-Founder

2004 - 2007

Worked with Arrowhead Research to start NanoPolaris, which eventually became Unidym and acquired Carbon Nanotechnologies, Inc. Unidym was acquired in January 2011 for $145M in total value.

Founder

2001 - 2004

Founded SWeNT, a manufacturer of single-walled carbon nanotubes, with technology from ConocoPhillips & the University of Oklahoma. The company grew from $0 to over $1.1M in revenue within my first 12 months. ConocoPhillips and a major global semiconductor company were investors/partners in the company. I left after 3 years, upon hiring a stellar CEO.

Co-Founder

2000 - 2002

Along with 3 other partners, licensed and developed technology from University of Sherbrooke, Quebec. NSTI manufactured nanoparticle titanium dioxide (TiO2) and other metal oxides for a variety of applications. Led the company's acquisition by DuPont in June 2002.